Literature DB >> 2727085

Systemic immunosuppression induced by photodynamic therapy (PDT) is adoptively transferred by macrophages.

D H Lynch, S Haddad, V J King, M J Ott, R C Straight, C J Jolles.   

Abstract

Some derivatives of hematoporphyrins are strongly retained by tumor tissue as compared to normal tissue, and exposure of these photosensitizers to radiation in the visible spectrum can cause serious biological damage. These properties have been exploited in the development of a new treatment for cancer termed photodynamic therapy (PDT). However, recent studies have also demonstrated that PDT can also induce a state of systemic immunosuppression. The purpose of this study was to determine whether PDT-induced suppression of contact hypersensitivity (CHS) responses was an active phenomenon that could be adoptively transferred by viable splenocytes from PDT-treated mice. Although induction of adoptively transferable suppressor cells in PDT-treated mice required exposure to antigen, the suppressor cells were found to be antigen nonspecific in their function. Furthermore, splenocytes from PDT-treated mice were capable of generating levels of allospecific cytotoxic T lymphocyte (CTL) activity which were comparable to those generated by normal control mice, but the ability of irradiated spleen cells from PDT-treated mice to stimulate a mixed lymphocyte response (MLR) was dramatically impaired. Finally, chromatographic separation of T cells, B cells and macrophages showed that the cell type which mediates adoptively transferable suppression of CHS responsiveness is in the macrophage lineage.

Entities:  

Mesh:

Year:  1989        PMID: 2727085     DOI: 10.1111/j.1751-1097.1989.tb09194.x

Source DB:  PubMed          Journal:  Photochem Photobiol        ISSN: 0031-8655            Impact factor:   3.421


  11 in total

Review 1.  Antibody-targeted polymer-bound drugs.

Authors:  B Ríhová
Journal:  Folia Microbiol (Praha)       Date:  1995       Impact factor: 2.099

Review 2.  Photodynamic Therapy and Immunity: An Update.

Authors:  Riddhi Falk-Mahapatra; Sandra O Gollnick
Journal:  Photochem Photobiol       Date:  2020-04-23       Impact factor: 3.421

Review 3.  The immunosuppressive side of PDT.

Authors:  Pawel Mroz; Michael R Hamblin
Journal:  Photochem Photobiol Sci       Date:  2011-03-24       Impact factor: 3.982

4.  Macrophage-directed immunotherapy as adjuvant to photodynamic therapy of cancer.

Authors:  M Korbelik; V R Naraparaju; N Yamamoto
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

5.  The immunosuppressive effects of phthalocyanine photodynamic therapy in mice are mediated by CD4+ and CD8+ T cells and can be adoptively transferred to naive recipients.

Authors:  Nabiha Yusuf; Santosh K Katiyar; Craig A Elmets
Journal:  Photochem Photobiol       Date:  2008-01-15       Impact factor: 3.421

6.  In vivo and in vitro activation of macrophages with a cyanine photosensitizing dye, platonin.

Authors:  Y Nakagawa; S Homma; I Yamamoto; M Banno; H Nakazato; H Imanaga; N Yamamoto
Journal:  Cancer Immunol Immunother       Date:  1993-08       Impact factor: 6.968

7.  Detection of anti-tumor immunity induced by laser immunotherapy.

Authors:  Wei R Chen; Raoul Carubelli; Hong Liu; Robert E Nordquist
Journal:  Mol Biotechnol       Date:  2003-09       Impact factor: 2.695

Review 8.  Photodynamic therapy.

Authors:  T J Dougherty; C J Gomer; B W Henderson; G Jori; D Kessel; M Korbelik; J Moan; Q Peng
Journal:  J Natl Cancer Inst       Date:  1998-06-17       Impact factor: 13.506

9.  Distribution of Photofrin between tumour cells and tumour associated macrophages.

Authors:  M Korbelik; G Krosl; P L Olive; D J Chaplin
Journal:  Br J Cancer       Date:  1991-09       Impact factor: 7.640

10.  Induction of immune cell infiltration into murine SCCVII tumour by photofrin-based photodynamic therapy.

Authors:  G Krosl; M Korbelik; G J Dougherty
Journal:  Br J Cancer       Date:  1995-03       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.